Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare May Soon Cover Ozempic, Wegovy
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce risks with obesity.
Drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal
Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.
Medicare Would Cover Ozempic and Wegovy Under Biden Proposal—Here's What That Means
The Biden administration proposed a rule to let Medicare and Medicaid cover obesity drugs like Ozempic. Millions would benefit, but it’s doubtful the incoming Trump administration will support it.
17h
on MSN
Novo Nordisk Is Scaling Back Its Hiring Spree in Denmark
Novo Nordisk A/S is cutting back on recruiting in Denmark after reaching the limits of its home country’s labor market in the ...
Wall Street Journal on MSN
15h
Novo Nordisk Says White House Obesity Plan Is Step in Right Direction
The Biden administration on Tuesday proposed that weight-loss drugs be paid for by Medicaid and Medicare, potentially making ...
Futurism on MSN
2d
Wait, Why Is Novo Selling Weight Loss Drugs for So Cheap in China?
Novo Nordisk has launched its weight-loss drug Wegovy in China — but for a tiny fraction of what it's charging customers in ...
5d
on MSN
Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
A dose of four Wegovy injections will cost 1,400 yuan ($194), a fraction of the drug’s U.S. price, according to the Chinese ...
1d
Novo Nordisk: Supply Strains, Competition, And RFK Concerns Mask Solid Fundamentals
Novo Nordisk faces challenges in weight-loss sector, but acquisition and strong diabetes portfolio position it for future ...
Bloomberg L.P.
1d
Novo Nordisk Foundation Targets US, Europe After Obesity Boost
The
Novo
Nordisk
Foundation’s assets have swelled with the success of diabetes and obesity treatments Ozempic and ...
19h
Novo, Lilly shares rise as Biden proposes obesity care coverage
Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden proposed expanding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Joe Biden
China
United States
Medicare
CagriSema
Feedback